z-logo
open-access-imgOpen Access
Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018
Author(s) -
D. E. Issa,
Rianne Seefat,
O. Visser,
Sonja Zweegman,
Pieternella J. Lugtenburg,
Avinash G. Dinmohamed,
Martine E.D. Chamuleau
Publication year - 2021
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2020009552
Subject(s) - medicine , rituximab , population , generalizability theory , relative survival , life expectancy , randomized controlled trial , lymphoma , burkitt's lymphoma , clinical trial , pediatrics , oncology , epidemiology , psychology , environmental health , cancer registry , developmental psychology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom